Meningitis Outbreak Prompts Call for Stricter Out-of-State Drug Rules
State officials are looking to tighten the rules on drugs from out-of-state. That decision arises from a deadly meningitis outbreak linked to contaminated injections.
No deaths have been reported in California. But about 600 people have received steroid shots from recalled batches linked to the Massachusetts compounding pharmacy suspected of manufacturing the tainted drugs.
Virginia Herold with the State Board of Pharmacy says the board doesn't "want California patients exposed to this kind of compounding where there isn't some accountability at a level that we currently can't reach."
Herold wants to make it harder for pharmacies that mix drugs to ship them to California - in part by requiring more from out-of-state accrediting agencies. "To require annual inspections, compliance against California standards for injectable compounding, and pharmacist review on our end before we renew the permit."
The board will take up the proposed legislation Thursday. Four California clinics received the recalled medicine batches.